Article Text

Download PDFPDF
Palatal perforation in a patient with borderline lepromatous leprosy: leprosy still not eradicated
  1. Preetha Anand1,
  2. Sujana Bharadwaj2,
  3. Satyaki Ganguly2 and
  4. Santhosh Rao1
  1. 1Dentistry-Oral & Maxillofacial Surgey, All India Institute of Medical Sciences, Raipur, Tatibandh, India
  2. 2Dermatology, All India Institute of Medical Sciences, Raipur, Tatibandh, India
  1. Correspondence to Dr Santhosh Rao; santhosh{at}


Leprosy was eliminated globally in 2000, but it continues to be endemic in developing countries like India, Brazil and Indonesia, with a prevalence of 0.57/10 000 persons in India (2020). At the end of the year 2020, the prevalence was 129 389, and oral manifestation of the leprosy is luncommon. We hereby report a case of a female patient in her late 30s who presented with palatal perforation. Following a thorough history taking and full body clinical examination, we arrived at a diagnosis of leprosy, and prompt treatment was initiated. Knowledge of cases like this becomes important as the oral lesion is said to form an essential source of leprosy dissemination in the community, and awareness about them becomes crucial, demanding immediate attention.

  • Dermatology
  • Dentistry and oral medicine

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors PA and SB did the patient care. SR and SG were the physicians. PA and SB prepared the manuscript, SR and SG reviewed the manuscript and edited it. All authors approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.